Professor Dr. Hagen v. Briesen studied biochemistry at the University of Frankfurt/Main (PhD in 1990). Since 2001 he had been assistant professor for Experimental Hematology at the University of Regensburg. Today he is Director of Division “Medical Biotechnology” at the Fraunhofer Institute for Biomedical Engineering (IBMT in Sulzbach/Saar, Germany) and Professor for Experimental Hematology at the University of Saarland. He is Principle Investigator of the Global HIV Vaccine Research Cryorepository (GHRC, Collaboration for AIDS Vaccine Discovery (CAVD)) (Bill & Melinda Gates Foundation), and is involved in joint research projects in cell programming by nanoscaled devices and nanoparticulate drug delivery systems (EU, BMBF and Federal Armed Forces). He is external expert in an interdisciplinary EU-funded support action on HIV-MTB co-infection “EUCO-Net”. He is co-founder of a start-up company (Analysis GmbH) for virus validation and safety studies where he introduced Good Laboratory Practice (GLP) as test facility manager. Hagen von Briesen was Principal Investigator of the Centralized Facility for the Isolation and Characterization of HIV within the WHO-Network, Global Program on AIDS, organized by the Joint United Nations Program on HIV/AIDS (UNAIDS). HIV-1 strains from different parts of the world were systematically isolated in his laboratory and characterized by the WHO Network. Concurrently, he was member of the trial management committee of the Mother-to-Child HIV-1 Transmission Study (UNAIDS-sponsored PETRA study) functioning as Head of Centralized Repository Centre and test laboratory. As of late, he is director of the Environmental Specimen Bank (UPB-human) of the Federal German Government.
- Position: Molecular/ Cellular Biosciences (translational –Omics)
- Affiliation: Fraunhofer IBMT
- Email: Hagen.Briesen@ibmt.fraunhofer.de